Latest OrphanDrug News and Updates : OrphanDrug updates, OrphanDrug News , OrphanDrug around the world

Nishadil

Washington | 19°C (overcast clouds)

A Glimmer of Hope: Lundbeck's Experimental Drug Shines in Early Cushing's Disease Trials

Top story

A Glimmer of Hope: Lundbeck's Experimental Drug Shines in Early Cushing's Disease Trials

In focus

Latest feed

A Beacon of Hope for a Devastating Rare Disease: BPGbio's Breakthrough

Zevra Therapeutics: A High-Stakes Bet in the Ultra-Rare Disease Arena

Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond

FDA Grants Priority Review to Rocket Pharma's Groundbreaking Gene Therapy for Rare LAD-I

Latest headlines

FDA Extends Review for Denali's Hunter Syndrome Breakthrough: A Closer Look at Tividenofusp Alfa's Path to Approval

FDA Extends Review for Denali's Hunter Syndrome Breakthrough: A Closer Look at Tividenofusp Alfa's Path to Approval

Ascendis Pharma Charts Course for EU Approval of TransCon CNP, Offering New Hope for Achondroplasia

Ascendis Pharma Charts Course for EU Approval of TransCon CNP, Offering New Hope for Achondroplasia

Novo Nordisk's Groundbreaking Hemophilia A Treatment Nears FDA Review

Novo Nordisk's Groundbreaking Hemophilia A Treatment Nears FDA Review

Palvella Therapeutics' QTORIN: A Glimmer of Hope Nears for Pachyonychia Congenita Sufferers

Palvella Therapeutics' QTORIN: A Glimmer of Hope Nears for Pachyonychia Congenita Sufferers

Lion TCR's LioCyx-HBV Secures Historic FDA IND Clearance, Marking a New Era in Chronic Hepatitis B Treatment After Fast Track and Orphan Drug Success

Lion TCR's LioCyx-HBV Secures Historic FDA IND Clearance, Marking a New Era in Chronic Hepatitis B Treatment After Fast Track and Orphan Drug Success

Wave Life Sciences Plummets 19%, But Long-Term Investors See a Silver Lining

Wave Life Sciences Plummets 19%, But Long-Term Investors See a Silver Lining

A New Dawn for RRP Patients: Papzimeos Secures Landmark FDA Approval, Redefining Care

A New Dawn for RRP Patients: Papzimeos Secures Landmark FDA Approval, Redefining Care

Load more